Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  17084 of 17156  at  9/23/2020 12:42:02 PM  by

sphericalkutz


 In response to msg 17082 by  Biotech_Jim
view thread

Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD

Jim: I continue to say I will add some shares in ACAD around 35.00 if it gets there. Your two stocks mentioned are way far away from any challenge to anything---especially the latter company. mentioned! Their track record is dubious. I like your first mention and put it on my watch list. But doesn't mean you can't make money in them. Just another waiting game for ACAD----brrrrr!!

JMO

kutz


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 372
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
17086 Re: Karuna Therapeutics in dementia-related psychosis, and Axovant Gene therapy in PD Biotech_Jim 3 9/23/2020 12:51:18 PM






Financial Market Data provided by
.
Loading...